There are unique regulatory and commercial issues to pay attention to, particularly for clients who receive grants from the Israel Innovation Authority (IIA, also formerly known as the Office of the Chief Scientist).
Navigating these hurdles can feel like a minefield. Public and private companies remain up to speed by tapping into the vast experience of ZAG’s Corporate and Capital Markets department in dealing with the IIA.
Our raft of services includes the preparation and filing of reports relating to equity financing, the preparation of licenses, structuring transactions, intellectual property transfers and negotiations on such transactions vis-à-vis the representatives of the IIA.
Given the potential risks involved, our combined strength across our international offices ensures clients get it right.
